CELG

Celgene Corporation Board of Directors Recommends to Our Stockholders a Two-for-One Stock Split

[Business Wire] – Celgene Corporation announced that the Board of Directors voted to recommend a two-for-one split of the Company’s common stock to be effected through an Amendment to moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboardSee who Celgene is hiring next, click here to view […]

Celgene Corporation to Present at Investor Conferences in February and March

[Business Wire] – Celgene Corporation announced that Celgene management will provide an overview of the Company at three upcoming investor conferences. The conferences will be webcast moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboardSee who Celgene is hiring next, click here to view […]

Health Canada Approves (Pr)POMALYST(TM) (Pomalidomide Capsules) Providing New Hope For Patients With Progressive Multiple Myeloma

[CNW Group] – Health Canada Approves (Pr)POMALYST(TM) (Pomalidomide Capsules) Providing New Hope For Patients With Progressive Multiple Myeloma moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboardSee who Celgene is hiring next, click here to view […]

The Vatican’s Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Announce Highlights of the Upcoming Second International Adult Stem Cell Conference

[at noodls] – Highlights Include Keynote by Nobel Prize Winner, Dr. John Gurdon New York, March 21, 2013 — The Stem for Life Foundation, NeoStem, Inc. (NYSE MKT:NBS), The Pontifical Council for Culture, and STOQ International … moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboardSee who Celgene is hiring next, click […]

Celgene Provides REVLIMID® Regulatory Update

[Business Wire] – BOUDRY, Switzerland–(BUSINESSWIRE)– Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that REVLIMID ® (lenalidomide) has been granted full approval, which … moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboardSee who Celgene is hiring next, click here to view […]

PropThink: Biogen Idec’s BG-12 PDUFA Delay is a Buying Opportunity

[ACN Newswire] – By Ivan DeryuginThe biotechnology sector can be broken up, at its simplest, into two distinct groups: the Big 4, and every other company. The Big 4 are Amgen (NASDAQ:AMGN), Celgene (NASDAQ:CELG), Gilead … moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboard […]

PropThink: Abraxane Data, Earnings Release Rally CELG; Back to Highs by Year End?

[ACN Newswire] – By Jake KingIn separate press releases on Thursday morning, Celgene (NASDAQ:CELG) reported 3Q results and announced that Abraxane demonstrated a statistically significant improvement in Progression Free … moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboard […]

PropThink: Celgene Nearing 52-week High on Abraxane Data, Upcoming PDUFA

[ACN Newswire] – By Jake KingCelgene (NASDAQ:CELG) moved closer today to securing another indication for its oncology drug, Abraxane, which is already approved as a second-line treatment for metastatic breast cancer. On … moreView todays social media effects on CELGView the latest stocks trending across Twitter. Click to view dashboard […]